ecancer

The 2022 OncoAlert Colloquium Day 6: EONS Sessions

Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden

31 Jan 2023

Optimisation of supportive, palliative and end of life care

Dr Zipporah Ali - Africa Organisation for Research & Training in Cancer, Kenya

20 Dec 2022

Talquetamab: Robust efficacy and manageable safety for heavily pretreated R/R multiple myeloma

Dr Ajai Chari - Mount Sinai School of Medicine, New York, USA

20 Dec 2022

What is required to advance data ethics, data sharing, and Open Science across LMICs

Dr Priya Kumari - Regional Cancer Centre Trivandrum, Trivandrum, India

20 Dec 2022

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Charles Gore - Medicines Patent Pool, Geneva, Switzerland

1 Dec 2022

Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival benefit in R/R multiple myeloma

Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA

12 Oct 2022

Intraoperative Radiotherapy

Dr Mahima Pant - National Academy for Medical Sciences (NAMS), Kathmandu, Nepal

25 Sep 2022

Cancer survivors' stories: An African perspective

Dr Zainab Shinkafi-Bagudu - Founder of the Medicaid Cancer Foundation

15 Sep 2022

ESMO 2022: Highlights, commentary and analysis

Dr Bishal Gyawali - Queen's University, Kingston, Canada

12 Sep 2022

A new era of early cancer detection with blood test may change cancer screening paradigms

Dr Deb Schrag, Memorial Sloan Kettering Cancer Center, New York, USA

11 Sep 2022

New era of early cancer detection blood tests on the horizon

Dr Deborah Schrag - Memorial Sloan Kettering Cancer Center, New York City, USA

11 Sep 2022

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

Dr Chris Labaki - Dana-Farber Cancer Institute, Boston, USA

11 Sep 2022

More from ecancer